UK Markets closed

NVO Oct 2023 110.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
53.00+21.00 (+65.62%)
At close: 10:59AM EDT
Full screen
Previous close0.00
Expiry date2023-10-20
Day's range53.00 - 53.00
Contract rangeN/A
Open interest10
  • Zacks

    Here's Why Investors Should Hold Ensign Group (ENSG) Stock Now

    Ensign Group (ENSG) remains well-poised for growth on the back of a growing revenue base, continuous pursuit of acquisitions and commendable financial position.

  • Zacks

    Scynexis (SCYX) Inks Antifungal Drug Deal With GSK

    Scynexis (SCYX) enters an exclusive license agreement with GSK to commercialize Brexafemme (ibrexafungerp), an antifungal tablet. GSK will also continue to develop ibrexafungerp for treating invasive candidiasis.

  • Motley Fool

    3 Stocks That Could Benefit From the Ozempic Craze

    Ozempic is a drug that has been soaring in popularity over the past year. Three companies that can benefit from the excitement around this weight-loss treatments are Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), and WW International (NASDAQ: WW). The biggest benefactor of Ozempic's popularity is likely to be the company that makes the treatment itself: Novo Nordisk.